P
TMDX icon

&Partners’s Transmedics TMDX Stock Holding History

&Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Sell
5,078
-59
-1% -$4.99K ﹤0.01% 2062
2026
Q1 		$511K Sell
5,137
-1,595
-24% -$208K ﹤0.01% 1683
2025
Q4 		$819K Buy
6,732
+264
+4% +$33.1K ﹤0.01% 1331
2025
Q3 		$726K Sell
6,468
-116
-2% -$13.6K ﹤0.01% 1244
2025
Q2 		$882K Sell
6,584
-462
-7% -$50.7K 0.01% 1043
2025
Q1 		$483K Buy
+7,046
New +$485K 0.01% 1151

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

&Partners's TMDX Position: Q2 2026 in Review

&Partners reduced its Transmedics (TMDX) stake by 1.1% in Q2 2026, selling an estimated $4.99K and leaving 5,078 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

&Partners first reported a position in TMDX in Q1 2025 and has held it in 6 quarters since. The position peaked at $882K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • &Partners held 5,078 shares of Transmedics worth $337K as of Q2 2026.
  • &Partners sold 59 Transmedics shares in Q2 2026, an estimated $4.99K.
  • Transmedics made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2062 holding.
  • &Partners first reported a position in Transmedics in Q1 2025 and has held it in 6 quarters since.
  • &Partners's Transmedics position peaked at $882K in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.